Iqvia Holdings INC. (IQV) — SEC Filings

Q: What are the key financial highlights for Iqvia Holdings INC.?

Key financial highlights for Iqvia Holdings INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Iqvia Holdings INC.?

Key executives at Iqvia Holdings INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Iqvia Holdings INC. stock?

Risk factors for Iqvia Holdings INC. (IQV) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Iqvia Holdings INC.?

Forward-looking statements and predictions from Iqvia Holdings INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Iqvia Holdings INC.. Recent S-8 filing on Apr 23, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Iqvia Holdings INC. on SEC EDGAR

Overview

Iqvia Holdings INC. (IQV) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 5, 2025: IQVIA Holdings Inc. filed an 8-K on November 5, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits.

Sentiment Summary

Across 27 filings, the sentiment breakdown is: 1 bullish, 25 neutral, 1 mixed. The dominant filing sentiment for Iqvia Holdings INC. is neutral.

Filing Type Overview

Iqvia Holdings INC. (IQV) has filed 1 S-8, 12 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 2 SC 13G, 2 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (27)

S-8 Filing — S-8 · Apr 23, 2026
8-K Filing — 8-K · Dec 9, 2025
IQVIA Holdings Inc. Files 8-K on Executive and Director Changes — 8-K · Nov 5, 2025 Risk: medium
IQVIA Holdings Inc. filed an 8-K on November 5, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of
IQVIA Q3 Revenue Jumps 5.2% to $4.1B, Net Income Up 16.1% — 10-Q · Oct 28, 2025 Risk: medium
IQVIA Holdings Inc. reported robust revenue growth for the three and nine months ended September 30, 2025. Revenues increased by 5.2% to $4.10 billion for the t
IQVIA Holdings Inc. Files 8-K on Executive and Director Changes — 8-K · Sep 2, 2025 Risk: medium
IQVIA Holdings Inc. filed an 8-K on September 2, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment o
IQVIA's Q2 Net Income Jumps 20%, Revenue Hits $3.9B — 10-Q · Jul 22, 2025 Risk: medium
IQVIA HOLDINGS INC. reported a net income of $300 million for the three months ended June 30, 2025, a significant increase from $250 million in the same period
IQVIA Holdings Inc. Enters Material Definitive Agreement — 8-K · Jun 4, 2025 Risk: medium
On June 4, 2025, IQVIA Holdings Inc. entered into a material definitive agreement, which also created a direct financial obligation for the registrant. The fili
IQVIA Holdings Files 8-K Report — 8-K · Jun 2, 2025 Risk: low
On June 2, 2025, IQVIA HOLDINGS INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updat
IQVIA Holdings Inc. Q1 2025 10-Q Filing — 10-Q · May 6, 2025 Risk: low
IQVIA Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter
IQVIA Holdings Inc. Files 8-K, Updates Fiscal Year End — 8-K · Apr 24, 2025 Risk: low
On April 24, 2025, IQVIA HOLDINGS INC. filed an 8-K report. The filing indicates a change in the company's fiscal year end to December 31st, with the most recen
IQVIA Holdings Inc. Enters Material Definitive Agreement — 8-K · Mar 10, 2025 Risk: medium
On March 10, 2025, IQVIA Holdings Inc. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or
IQVIA Holdings Inc. DEF 14A Filing — DEF 14A · Feb 28, 2025 Risk: low
IQVIA Holdings Inc. filed its DEF 14A on February 28, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other co
IQVIA Holdings Inc. Files 2024 10-K — 10-K · Feb 13, 2025 Risk: medium
IQVIA Holdings Inc. filed its 2024 10-K on February 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Quintiles IM
IQVIA Holdings Inc. Files 8-K on Financials — 8-K · Feb 6, 2025 Risk: low
On February 6, 2025, IQVIA Holdings Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
IQVIA Holdings Inc. Files Q3 2024 10-Q — 10-Q · Oct 31, 2024 Risk: low
IQVIA Holdings Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024 and provides financial details for the
SC 13G Filing — SC 13G · Aug 15, 2024
IQVIA Holdings Inc. Files Q2 2024 10-Q Report — 10-Q · Jul 22, 2024 Risk: low
IQVIA HOLDINGS INC. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024 and provides financial updates. The company
IQVIA Appoints New CFO, Michael R. R. McLellan — 8-K · May 10, 2024 Risk: medium
IQVIA Holdings Inc. announced on May 10, 2024, that its Board of Directors appointed Michael R. R. McLellan as Chief Financial Officer, effective May 6, 2024. H
IQVIA Holdings Inc. Files 8-K on Financials — 8-K · May 2, 2024 Risk: low
IQVIA Holdings Inc. filed an 8-K on May 2, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and ex
IQVIA Holdings Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024 Risk: low
IQVIA HOLDINGS INC. (IQV) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. IQVIA Holdings Inc. filed its 10-Q report for the quarterly period ended
IQVIA Holdings Inc. Files 8-K on Shareholder Vote Matters — 8-K · Apr 17, 2024 Risk: low
IQVIA Holdings Inc. filed an 8-K on April 17, 2024, reporting on matters submitted to a vote of security holders on April 16, 2024. The filing does not contain
IQVIA HOLDINGS INC. Files Definitive Proxy Statement — DEF 14A · Feb 23, 2024 Risk: low
IQVIA HOLDINGS INC. (IQV) filed a Proxy Statement (DEF 14A) with the SEC on February 23, 2024. IQVIA HOLDINGS INC. filed a Definitive Proxy Statement (DEF 14A)
IQVIA Holdings Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024 Risk: medium
IQVIA HOLDINGS INC. (IQV) filed a Annual Report (10-K) with the SEC on February 15, 2024. IQVIA Holdings Inc. filed its 2023 Form 10-K on February 15, 2024. The
IQVIA Files 8-K on Financial Results and Operations — 8-K · Feb 14, 2024 Risk: low
IQVIA Holdings Inc. filed an 8-K on February 14, 2024, to report on its results of operations and financial condition, along with related financial statements a
SC 13G Filing — SC 13G · Feb 14, 2024
SC 13G/A Filing — SC 13G/A · Feb 13, 2024
BlackRock Amends IQVIA Holdings Stake, Passive Investment Update — SC 13G/A · Jan 25, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 25, 2024, indicating its ownership of IQVIA HOLDINGS INC. common stock as of December 31, 2023. This f

Risk Profile

Risk Assessment: Of IQV's 21 recent filings, 0 were flagged as high-risk, 9 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Iqvia Holdings INC.'s most recent 10-Q filing (Oct 28, 2025):

Revenue: $4.10B
Net Income: $331M
EPS: $1.93
Cash Position: $1.814B

Key Executives

Michael R. R. McLellan
Michael J. Venn
Ari Bousbib

Industry Context

IQVIA operates in the highly competitive life sciences services sector, providing a broad range of solutions from clinical development to commercialization. The industry is characterized by increasing demand for data analytics, real-world evidence, and digital health solutions. Key trends include the growing complexity of clinical trials, the need for faster drug development, and the impact of regulatory changes globally.

Top Tags

10-Q (4) · financials (4) · filing (3) · executive-changes (2) · Clinical Research (2) · Healthcare Technology (2) · financial-obligation (2) · 8-K (2) · quarterly-report (2) · corporate-governance (2)

Executive Compensation

From the most recent DEF 14A filing (Feb 23, 2024):

Ari Bousbib — Member
Ron E. Bruehlman — Member
W. Richard Staub III — Member

Key Numbers

Q3 2025 Revenues: $4.10B — Increased 5.2% from $3.896B in Q3 2024
YTD 2025 Revenues: $11.95B — Increased 4.4% from $11.447B in YTD 2024
Q3 2025 Net Income: $331M — Increased 16.1% from $285M in Q3 2024
YTD 2025 Net Income: $846M — Decreased 9.6% from $936M in YTD 2024
Q3 2025 Diluted EPS: $1.93 — Increased from $1.55 in Q3 2024
YTD 2025 Diluted EPS: $4.86 — Decreased from $5.08 in YTD 2024
Remaining Performance Obligations: $34.4B — 85% expected to be recognized over the next five years
Current Portion of Long-Term Debt: $2.164B — Increased from $1.145B at December 31, 2024
Common Stock Repurchases: $1.032B — For the nine months ended September 30, 2025
Shares Outstanding: 170.3M — As of October 20, 2025
Net Income Q2 2025: $300M — Increased 20% from $250M in Q2 2024
Revenue Q2 2025: $3.9B — Up from $3.7B in Q2 2024
Total Assets: $28.5B — As of June 30, 2025, indicating strong financial position
Treasury Stock: $9.8B — Decreased from $10.2B, suggesting share repurchases
Retained Earnings: $13.1B — Increased from $12.5B, reflecting profitable operations

Related Companies

LH · SYNH

Frequently Asked Questions

What are the latest SEC filings for Iqvia Holdings INC. (IQV)?

Iqvia Holdings INC. has 27 recent SEC filings from Jan 2024 to Apr 2026, including 12 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of IQV filings?

Across 27 filings, the sentiment breakdown is: 1 bullish, 25 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Iqvia Holdings INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Iqvia Holdings INC. (IQV) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Iqvia Holdings INC.?

Key financial highlights from Iqvia Holdings INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for IQV?

The investment thesis for IQV includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Iqvia Holdings INC.?

Key executives identified across Iqvia Holdings INC.'s filings include Michael R. R. McLellan, Michael J. Venn, Ari Bousbib.

What are the main risk factors for Iqvia Holdings INC. stock?

Of IQV's 21 assessed filings, 0 were flagged high-risk, 9 medium-risk, and 12 low-risk.

What are recent predictions and forward guidance from Iqvia Holdings INC.?

Forward guidance and predictions for Iqvia Holdings INC. are extracted from SEC filings as they are enriched.